NDC 64764-175

Dexilant

Dexlansoprazole

Dexilant is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Dexlansoprazole.

• Product ID: 64764-175_46c355cb-10d1-4364-a4a8-891d97a7e88d
• NDC: 64764-175
• Product Type: Human Prescription Drug
• Proprietary Name: Dexilant
• Generic Name: Dexlansoprazole
• Dosage Form: Capsule, Delayed Release
• Route of Administration: ORAL
• Marketing Start Date: 2010-04-12
• Marketing Category: NDA / NDA
• Application Number: NDA022287
• Labeler Name: Takeda Pharmaceuticals America, Inc.
• Substance Name: DEXLANSOPRAZOLE
• Active Ingredient Strength: 60 mg/1
• Pharm Classes: Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 64764-175-00

7 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-00)

• Marketing Start Date: 2010-04-12
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 64764-175-01 [64764017501]

Dexilant CAPSULE, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA022287
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2010-04-12

NDC 64764-175-00 [64764017500]

Dexilant CAPSULE, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA022287
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2010-04-12

NDC 64764-175-02 [64764017502]

Dexilant CAPSULE, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA022287
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2010-04-12

NDC 64764-175-11 [64764017511]

Dexilant CAPSULE, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA022287
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2010-04-12

NDC 64764-175-30 [64764017530]

Dexilant CAPSULE, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA022287
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2010-04-12

NDC 64764-175-90 [64764017590]

Dexilant CAPSULE, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA022287
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2010-04-12

NDC 64764-175-19 [64764017519]

Dexilant CAPSULE, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA022287
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2010-04-12

Drug Details

Active Ingredients

Ingredient	Strength
DEXLANSOPRAZOLE	60 mg/1

OpenFDA Data

• SPL SET ID: 9819f033-3bbe-442e-8e92-45fec77b237d
• Manufacturer:
  • Takeda Pharmaceuticals America, Inc.
• UNII:
  • UYE4T5I70X
• RxNorm Concept Unique ID - RxCUI:
  • 833213
  • 902626
  • 833204
  • 902624
• UPC Code:
  • 0364764175306
  • 0364764171308

Pharmacological Class

• Proton Pump Inhibitor [EPC]
• Proton Pump Inhibitors [MoA]
• Proton Pump Inhibitor [EPC]
• Proton Pump Inhibitors [MoA]

Medicade Reported Pricing

64764017590 DEXILANT DR 60 MG CAPSULE

Pricing Unit: EA | Drug Type:

64764017530 DEXILANT DR 60 MG CAPSULE

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Dexilant" or generic name "Dexlansoprazole"

NDC	Brand Name	Generic Name
50090-4374	Dexilant	dexlansoprazole
55154-5154	Dexilant	dexlansoprazole
64764-171	Dexilant	dexlansoprazole
64764-175	Dexilant	dexlansoprazole
24979-001	Dexlansoprazole	dexlansoprazole
24979-002	Dexlansoprazole	dexlansoprazole
24979-703	Dexlansoprazole	dexlansoprazole
24979-704	Dexlansoprazole	dexlansoprazole
49884-148	Dexlansoprazole	Dexlansoprazole
50090-5944	Dexlansoprazole	dexlansoprazole
50090-5956	Dexlansoprazole	dexlansoprazole